Central Lab: Biomarker & Assay Development Services

Biomarker and Assay Development Services

We have capabilities in cell, fluid and tissue-based biomarkers from initial identification and qualification, validation and dissemination, through to production.

Assay Development Laboratory

When developing assays, Quintiles offers:

  • Validation plans & reports
  • Sponsor approval and signatures
  • Writing the method SOP
  • Preparing a detailed technology transfer document (including instrument programming)
  • Training of the Clinical Lab Staff
  • Setting up and supplying in-house PT specimens (bi-yearly to quarterly)

We focus on the in-sourcing of new and emerging biomarkers relevant to your needs:

  • Elisa, Luminex and biochip technologies
  • Flow Cytometry and cell-based technologies 
  • GC/MS and LC/MS Molecular Biology 
  • Technology Transfers (i.e. Immunogenicity)

The Science Behind Our Central Labs

Going well beyond safety testing, Quintiles Central Labs are backed by deep scientific expertise. Learn what our experts have been working on lately.

Learn more

Future of Biomarkers, Digital Pathology and Personalized Medicine in PharmaAsia

Christopher Ung, Vice President, Strategic Business and Operations, Oncology, article in the January/February 2010 issue of PharmaAsia.

Read More

Perspectives

Podcast: Changing the Face of Cancer Research

Christopher Ung, Vice President, Strategic Business & Operations, Oncology, Quintiles, explains how advances in biomarker technology are ushering in a new era of cancer therapy development.

Find out more

Quintiles Translational Oncology Services

Learn more about Quintiles oncology services and leadership in the area of translational R&D.

Learn More